Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

PHASE3CompletedINTERVENTIONAL
Enrollment

734

Participants

Timeline

Start Date

July 20, 2009

Primary Completion Date

September 28, 2012

Study Completion Date

January 26, 2018

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Brivanib

Tablets, Oral, 200 mg, once daily, until disease progression or toxicity

OTHER

Brivanib Placebo

Tablets, Oral, 0 mg, once daily, until disease progression or toxicity

PROCEDURE

TACE Therapy

Trans-Arterial Chemo-Embolization Therapy

Trial Locations (94)

100

Local Institution, Taipei

112

Local Institution, Taipei

333

Local Institution, Taoyuan District

404

Local Institution, Taichung

704

Local Institution, Tainan City

3050

Local Institution, Parkville

8520

Local Institution, New Territories

8525

Local Institution, Hong Kong

10400

Local Institution, Bangkok

10700

Local Institution, Bangkok

13385

Local Institution, Marseille

16132

Local Institution, Genova

22908

University Of Virginia Health System, Charlottesville

28007

Local Institution, Madrid

28222

Local Institution, Madrid

30060

Local Institution, Tianjin

31059

Local Institution, Toulouse

33075

Local Institution, Bordeaux

35128

Local Institution, Padua

38043

Local Institution, Grenoble

46010

Local Institution, Valencia

46014

Local Institution, Valencia

49933

Local Institution, Angers

56124

Local Institution, Pisa

59037

Local Institution, Lille

69317

Local Institution, Lyon

75012

Local Institution, Paris

75013

Local Institution, Paris

77030

The University Of Texas MD Anderson Cancer Center, Houston

80756

Local Institution, Kaohsiung City

90095

Richard Finn, M.D., Los Angeles

92118

Local Institution, Clichy

92123

Sharp Clinical Oncology Research, San Diego

93143

Local Institution, Bondy

94010

Local Institution, Créteil

100071

Local Institution, Beijing

130021

Local Institution, Changchun

150081

Local Institution, Harbin

200032

Local Institution, Shanghai

200433

Local Institution, Shanghai

210000

Local Institution, Nanjing

210002

Local Institution, Nanjing

210009

Local Institution, Nanjing

213003

Local Institution, Changzhou

215006

Local Institution, Suzhou

310022

Local Institution, Hangzhou

410013

Local Institution, Changsha

530021

Local Institution, Nanning

609735

Local Institution, Busan

610041

Local Institution, Chengdu

610080

Local Institution, Guanzhou

700721

Local Institution, Taegu

710032

Local Institution, Xi'an

2138587

Local Institution, Kawasaki-shi

2608677

Local Institution, Chiba

5038502

Local Institution, Ogaki-shi

5148507

Local Institution, Tsu

5378511

Local Institution, Higashinari-ku

5438555

Local Institution, Osaka

5890014

Local Institution, Ōsaka-sayama

6028566

Local Institution, Kyoto

6638501

Local Institution, Nishinomiya-shi

7370023

Local Institution, Kure-shi

7818555

Local Institution, Kochi

8608556

Local Institution, Kumamoto

9208641

Local Institution, Kanazawa

9308550

Local Institution, Toyama

10467-2401

Montefiore Medical Center, The Bronx

02903

Rhode Island Hospital, Providence

98109-1023

Seattle Cancer Care Alliance, Seattle

C1405BCK

Local Institution, Capital Federal

C1181ACH

Local Institution, Buenos Aires

V5Z 1M9

Local Institution, Vancouver

H2X 3J4

Local Institution, Montreal

00168

Local Institution, Roma

470-1101

Local Institution, Toyoake

277-0882

Local Institution, Kashiwa-shi

734-0037

Local Institution, Hiroshima

060-0033

Local Institution, Sapporo

232-0024

Local Institution, Yokohama

700-0082

Local Institution, Okayama

534-0021

Local Institution, Osaka

545-8586

Local Institution, Osaka

411-8777

Local Institution, Sunto-gun

104-0045

Local Institution, Chuo-ku

105-0001

Local Institution, Minato-ku

180-0023

Local Institution, Musashino-shi

463-707

Local Institution, Kyunggi-do

110-744

Local Institution, Seoul

120-752

Local Institution, Seoul

135-710

Local Institution, Seoul

137-701

Local Institution, Seoul

138-736

Local Institution, Seoul

443-721

Local Institution, Suwon

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY